Alector Inc. (ALEC) NASDAQ

$8.86 0.07 (0.80%)

Market Cap: $738.28M

As of 05/25/22 04:00 PM EDT. Market closed.

(ALEC)

Alector Inc. (ALEC) NASDAQ

$8.86 0.07 (0.80%)

Market Cap: $738.28M

As of 05/25/22 04:00 PM EDT. Market closed.

Alector is a clinical stage biotechnology company pioneering immuno-neurology, a novel therapeutic approach for the treatment of neurodegenerative diseases. The Company is developing a broad portfolio of innate immune system programs, designed to functionally repair genetic mutations that cause dysfunction of the brain's immune system and enable the rejuvenated immune cells to counteract emerging ... read more

Alector is a clinical stage biotechnology company pioneering immuno-neurology, a novel therapeutic approach for the treatment of neurodegenerative diseases. The Company is developing a broad portfolio of innate immune system programs, designed to functionally repair genetic mutations that cause dysfunction of the brain's immune system and enable the rejuvenated immune cells to counteract emerging brain pathologies. Immuno-neurology targets immune dysfunction as a root cause of multiple pathologies that are drivers of degenerative brain disorders. The Company's immuno-neurology product candidates are supported by biomarkers and target genetically defined patient populations in frontotemporal dementia and Alzheimer's disease. This scientific approach is also the basis for the Company's immuno-oncology programs. read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Biological Product (except Diagnostic) Manufacturing
CEO
Arnon Rosenthal
Full Time Employees
171
CEO Compensation (Base)
$396,764
CEO Compensation (Total)
$5.45M
URL
Address
151 Oyster Point Blvd Ste 300, California, South San Francisco, 94080-1841.
Sector
Manufacturing
Industry
Biological Product (except Diagnostic) Manufacturing
CEO
Arnon Rosenthal
Full Time Employees
171
CEO Compensation (Base)
$396,764
CEO Compensation (Total)
$5.45M
Address
151 Oyster Point Blvd Ste 300, California, South San Francisco, 94080-1841.
PRICE CHART
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
KEY STATS
Open
$8.97
Previous Close
$8.79
Days Range
$8.51 - $8.97
52 week range
$7.50 - $43.32
Volume
604,197
Avg. Volume (30 days)
784,598
Market Cap
$738.28M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
83,326,922
Open
$8.97
Previous Close
$8.79
Days Range
$8.51 - $8.97
52 week range
$7.50 - $43.32
Volume
604,197
Avg. Volume (30 days)
784,598
Market Cap
$738.28M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
83,326,922

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR ALECTOR INC
Owner Relationship Date Transaction Cost # Shares Value($) Total Shares Form 4
King Robert Chief Development Officer Mar 01, 2022 Sale $15.57 287 4,468 528,404 Mar 03, 2022, 05:41 PM
SULIMAN SHEHNAAZ President and COO Dec 10, 2021 Option Exercise $17.23 75,000 1,292,250 177,598 Dec 14, 2021, 08:23 PM
SULIMAN SHEHNAAZ President and COO Dec 13, 2021 Option Exercise $17.23 75,000 1,292,250 177,598 Dec 14, 2021, 08:23 PM
SULIMAN SHEHNAAZ President and COO Dec 10, 2021 Sale $21.76 75,000 1,632,167 111,472 Dec 14, 2021, 08:23 PM
SULIMAN SHEHNAAZ President and COO Dec 13, 2021 Sale $21.24 75,000 1,593,149 113,496 Dec 14, 2021, 08:23 PM
SULIMAN SHEHNAAZ President and COO Dec 08, 2021 Option Exercise $12.09 75,000 906,493 177,598 Dec 10, 2021, 07:20 PM
SULIMAN SHEHNAAZ President and COO Dec 09, 2021 Option Exercise $17.23 75,000 1,292,250 177,598 Dec 10, 2021, 07:20 PM
SULIMAN SHEHNAAZ President and COO Dec 09, 2021 Sale $22.82 75,000 1,711,843 105,241 Dec 10, 2021, 07:20 PM
SULIMAN SHEHNAAZ President and COO Dec 08, 2021 Sale $22.79 75,000 1,709,316 141,087 Dec 10, 2021, 07:20 PM
King Robert Chief Development Officer Dec 01, 2021 Sale $20.09 250 5,023 528,691 Dec 03, 2021, 05:08 PM
Rosenthal Arnon Chief Executive Officer Nov 11, 2021 Sale $25.00 55,000 1,375,000 1,972,875 Nov 12, 2021, 06:36 PM
Rosenthal Arnon Chief Executive Officer Nov 10, 2021 Sale $25.00 55,000 1,375,000 2,027,875 Nov 12, 2021, 06:36 PM
Rosenthal Arnon Chief Executive Officer Nov 08, 2021 Sale $25.00 100,000 2,500,000 2,137,875 Nov 10, 2021, 07:07 PM
Rosenthal Arnon Chief Executive Officer Nov 09, 2021 Sale $25.00 100,000 2,500,000 2,082,875 Nov 10, 2021, 07:07 PM
Rosenthal Arnon Chief Executive Officer Nov 05, 2021 Sale $25.00 100,000 2,500,000 2,192,875 Nov 08, 2021, 06:39 PM
Rosenthal Arnon Chief Executive Officer Nov 04, 2021 Sale $25.00 100,000 2,500,000 2,247,875 Nov 08, 2021, 06:39 PM
Rosenthal Arnon Chief Executive Officer Sep 23, 2021 Sale $25.10 9,625 241,567 2,302,875 Sep 23, 2021, 09:12 PM
Rosenthal Arnon Chief Executive Officer Sep 22, 2021 Sale $25.33 100,000 2,533,188 2,317,783 Sep 23, 2021, 09:12 PM
Rosenthal Arnon Chief Executive Officer Sep 20, 2021 Sale $25.80 100,000 2,580,391 2,520,546 Sep 22, 2021, 04:54 PM
Rosenthal Arnon Chief Executive Officer Sep 21, 2021 Sale $26.11 100,000 2,611,437 2,420,962 Sep 22, 2021, 04:54 PM
Paul Robert Chief Medical Officer Aug 09, 2021 Option Exercise $10.69 22,950 245,245 257,269 Aug 11, 2021, 06:23 PM
Paul Robert Chief Medical Officer Aug 09, 2021 Sale $27.18 22,950 623,767 234,619 Aug 11, 2021, 06:23 PM
SCHELLER RICHARD H Director Aug 05, 2021 Option Exercise $10.14 56,260 570,476 56,260 Aug 09, 2021, 06:13 PM
SCHELLER RICHARD H Director Jul 02, 2021 Sale $31.14 9,981 310,808 0 Aug 09, 2021, 06:13 PM
SCHELLER RICHARD H Director Aug 05, 2021 Sale $27.68 56,260 1,557,341 3,392 Aug 09, 2021, 06:13 PM
Paul Robert Chief Medical Officer Jul 07, 2021 Option Exercise $12.15 29,749 361,340 264,068 Jul 08, 2021, 06:24 PM
Paul Robert Chief Medical Officer Jul 06, 2021 Option Exercise $17.15 30,000 514,500 264,319 Jul 08, 2021, 06:24 PM
Paul Robert Chief Medical Officer Jul 07, 2021 Sale $38.70 29,749 1,151,237 259,168 Jul 08, 2021, 06:24 PM
Paul Robert Chief Medical Officer Jul 06, 2021 Sale $37.31 30,000 1,119,167 254,095 Jul 08, 2021, 06:24 PM
Yu Calvin Vice President, Finance Jul 06, 2021 Option Exercise $13.03 3,334 43,429 80,020 Jul 07, 2021, 07:38 PM
Yu Calvin Vice President, Finance Jul 02, 2021 Option Exercise $13.13 60,840 798,948 187,526 Jul 07, 2021, 07:38 PM
Yu Calvin Vice President, Finance Jul 06, 2021 Sale $34.65 3,334 115,523 76,686 Jul 07, 2021, 07:38 PM
Yu Calvin Vice President, Finance Jul 02, 2021 Sale $32.74 110,840 3,629,078 96,686 Jul 07, 2021, 07:38 PM
King Robert Chief Development Officer Jul 02, 2021 Option Exercise $9.15 60,000 549,000 582,317 Jul 07, 2021, 07:02 PM
King Robert Chief Development Officer Jul 02, 2021 Sale $31.14 60,000 1,868,400 522,317 Jul 07, 2021, 07:02 PM
Paul Robert Chief Medical Officer Jul 02, 2021 Option Exercise $17.15 17,326 297,141 264,319 Jul 06, 2021, 06:14 PM
Paul Robert Chief Medical Officer Jul 02, 2021 Sale $31.14 30,000 934,200 234,319 Jul 06, 2021, 06:14 PM
Paul Robert Chief Medical Officer Jul 01, 2021 Sale $22.23 26,726 594,124 246,993 Jul 06, 2021, 06:14 PM
Paul Robert Chief Medical Officer Jun 08, 2021 Option Exercise $9.39 19,175 179,996 292,894 Jun 10, 2021, 05:24 PM
Paul Robert Chief Medical Officer Jun 08, 2021 Sale $19.18 19,175 367,745 276,719 Jun 10, 2021, 05:24 PM
Yu Calvin Vice President, Finance Jun 02, 2021 Sale $17.77 1,844 32,768 126,686 Jun 03, 2021, 07:39 PM
Paul Robert Chief Medical Officer Apr 07, 2021 Option Exercise $9.60 22,300 214,186 236,019 Apr 08, 2021, 08:18 PM
Paul Robert Chief Medical Officer Apr 07, 2021 Sale $19.20 22,300 428,050 213,764 Apr 08, 2021, 08:18 PM
Paul Robert Chief Medical Officer Mar 22, 2021 Option Exercise $8.16 30,000 244,800 243,719 Mar 24, 2021, 04:36 PM
Paul Robert Chief Medical Officer Mar 23, 2021 Option Exercise $8.16 13,800 112,608 227,519 Mar 24, 2021, 04:36 PM
Paul Robert Chief Medical Officer Mar 22, 2021 Sale $22.98 30,000 689,376 219,229 Mar 24, 2021, 04:36 PM
Paul Robert Chief Medical Officer Mar 23, 2021 Sale $22.21 13,800 306,498 213,719 Mar 24, 2021, 04:36 PM
Paul Robert Chief Medical Officer Mar 09, 2021 Option Exercise $8.38 19,175 160,592 232,894 Mar 10, 2021, 06:29 PM
Paul Robert Chief Medical Officer Mar 09, 2021 Sale $18.12 19,175 347,405 213,719 Mar 10, 2021, 06:29 PM
Paul Robert Chief Medical Officer Feb 09, 2021 Option Exercise $8.38 19,175 160,594 232,894 Feb 11, 2021, 05:08 PM
Paul Robert Chief Medical Officer Feb 09, 2021 Sale $20.81 19,175 399,055 213,719 Feb 11, 2021, 05:08 PM
Paul Robert Chief Medical Officer Jan 26, 2021 Option Exercise $8.46 27,308 231,082 241,027 Jan 27, 2021, 06:53 PM
Paul Robert Chief Medical Officer Jan 25, 2021 Option Exercise $8.30 30,000 248,926 243,719 Jan 27, 2021, 06:53 PM
Paul Robert Chief Medical Officer Jan 26, 2021 Sale $18.00 27,308 491,544 213,719 Jan 27, 2021, 06:53 PM
Paul Robert Chief Medical Officer Jan 25, 2021 Sale $18.01 30,000 540,225 213,719 Jan 27, 2021, 06:53 PM
Paul Robert Chief Medical Officer Jan 20, 2021 Option Exercise $8.64 8,567 74,031 222,286 Jan 21, 2021, 06:46 PM
Paul Robert Chief Medical Officer Jan 19, 2021 Option Exercise $8.30 30,000 248,924 243,719 Jan 21, 2021, 06:46 PM
Paul Robert Chief Medical Officer Jan 19, 2021 Sale $18.12 30,000 543,552 213,719 Jan 21, 2021, 06:46 PM
Paul Robert Chief Medical Officer Jan 20, 2021 Sale $18.00 8,567 154,211 213,719 Jan 21, 2021, 06:46 PM
Paul Robert Chief Medical Officer Jul 15, 2020 Sale $22.96 10,000 229,642 214,097 Jul 17, 2020, 04:43 PM
MCGUIRE TERRANCE Director Jun 23, 2020 Sale $31.54 4,377 138,063 12,853,817 Jun 25, 2020, 05:53 PM
Polaris Venture Management Co. VI, L.L.C. 10% Owner Jun 23, 2020 Sale $31.54 4,377 138,063 12,853,817 Jun 25, 2020, 05:47 PM
Paul Robert Chief Medical Officer Jun 15, 2020 Sale $29.61 10,000 296,137 227,628 Jun 17, 2020, 04:21 PM
Yu Calvin Vice President, Finance Jun 03, 2020 Sale $31.26 1,343 41,981 110,986 Jun 05, 2020, 04:40 PM
Paul Robert Chief Medical Officer May 15, 2020 Sale $27.00 10,000 270,026 241,819 May 19, 2020, 05:23 PM
King Robert Chief Development Officer May 15, 2020 Sale $27.00 15,000 404,958 488,952 May 19, 2020, 05:23 PM
Paul Robert Chief Medical Officer Apr 15, 2020 Sale $22.27 10,000 222,700 243,719 Apr 17, 2020, 05:12 PM
ORBIMED ADVISORS LLC 10% Owner Apr 16, 2020 Sale $23.53 62,183 1,463,166 5,955,674 Apr 16, 2020, 08:23 PM
ORBIMED ADVISORS LLC 10% Owner Apr 14, 2020 Sale $23.52 23,231 546,393 6,002,771 Apr 16, 2020, 08:23 PM
ORBIMED ADVISORS LLC 10% Owner Apr 09, 2020 Sale $23.79 288,101 6,853,923 6,020,366 Apr 09, 2020, 05:30 PM
ORBIMED ADVISORS LLC 10% Owner Apr 08, 2020 Sale $23.65 82,614 1,953,821 6,238,574 Apr 09, 2020, 05:30 PM
ORBIMED ADVISORS LLC 10% Owner Apr 07, 2020 Sale $23.10 9,170 211,827 6,301,147 Apr 09, 2020, 05:30 PM
ORBIMED ADVISORS LLC 10% Owner Mar 31, 2020 Sale $24.50 250,000 6,125,000 6,308,093 Apr 02, 2020, 05:06 PM
ORBIMED ADVISORS LLC 10% Owner Mar 25, 2020 Sale $24.66 56,411 1,391,095 6,497,448 Mar 25, 2020, 05:54 PM
ORBIMED ADVISORS LLC 10% Owner Mar 24, 2020 Sale $24.45 67,644 1,653,896 6,540,175 Mar 25, 2020, 05:54 PM
ORBIMED ADVISORS LLC 10% Owner Mar 23, 2020 Sale $26.05 14,598 380,278 6,591,410 Mar 25, 2020, 05:54 PM
Paul Robert Chief Medical Officer Mar 13, 2020 Sale $22.93 10,000 229,286 262,238 Mar 17, 2020, 07:07 PM
ORBIMED ADVISORS LLC 10% Owner Mar 02, 2020 Sale $26.00 1,874,203 48,729,278 6,602,467 Mar 04, 2020, 12:00 AM
King Robert Chief Development Officer Feb 14, 2020 Sale $29.56 15,000 443,376 502,649 Feb 18, 2020, 05:00 PM
Paul Robert Chief Medical Officer Feb 14, 2020 Sale $29.54 10,000 295,390 270,719 Feb 18, 2020, 05:00 PM
Oney Sabah Chief Business Officer Feb 07, 2020 Sale $35.03 19,900 697,097 573,918 Feb 11, 2020, 05:53 PM
Yu Calvin Vice President, Finance Feb 06, 2020 Option Exercise $8.95 1,821 16,295 127,115 Feb 10, 2020, 04:42 PM
Yu Calvin Vice President, Finance Feb 07, 2020 Option Exercise $9.59 10,225 98,088 134,719 Feb 10, 2020, 04:42 PM
Yu Calvin Vice President, Finance Feb 06, 2020 Sale $35.00 2,621 91,735 124,494 Feb 10, 2020, 04:42 PM
Yu Calvin Vice President, Finance Feb 07, 2020 Sale $35.02 24,033 841,636 110,686 Feb 10, 2020, 04:42 PM
Paul Robert Chief Medical Officer Feb 05, 2020 Option Exercise $8.16 10,000 81,600 283,719 Feb 07, 2020, 08:11 PM
Paul Robert Chief Medical Officer Feb 05, 2020 Sale $32.10 10,000 321,000 273,719 Feb 07, 2020, 08:11 PM
Oney Sabah Chief Business Officer Feb 04, 2020 Option Exercise $8.16 16,667 136,003 610,585 Feb 06, 2020, 05:48 PM
Oney Sabah Chief Business Officer Feb 06, 2020 Sale $35.00 100 3,500 593,818 Feb 06, 2020, 05:48 PM
Oney Sabah Chief Business Officer Feb 04, 2020 Sale $30.00 16,667 500,010 593,918 Feb 06, 2020, 05:48 PM
SCHELLER RICHARD H Director Feb 04, 2020 Sale $29.67 10,000 296,700 9,981 Feb 06, 2020, 05:19 PM
Yu Calvin Vice President, Finance Feb 04, 2020 Option Exercise $8.16 13,541 110,495 188,835 Feb 06, 2020, 05:18 PM
Yu Calvin Vice President, Finance Feb 04, 2020 Sale $30.04 63,541 1,908,772 125,294 Feb 06, 2020, 05:18 PM
Wehner David M. Director Feb 03, 2020 Buy $25.00 20,000 500,000 44,621 Feb 03, 2020, 06:19 PM
Paul Robert Chief Medical Officer Jan 30, 2020 Option Exercise $8.16 8,000 65,280 281,719 Feb 03, 2020, 06:14 PM
Paul Robert Chief Medical Officer Jan 30, 2020 Sale $28.00 8,000 224,000 273,719 Feb 03, 2020, 06:14 PM
Oney Sabah Chief Business Officer Jan 23, 2020 Option Exercise $8.16 2,200 17,952 596,118 Jan 27, 2020, 05:41 PM
Oney Sabah Chief Business Officer Jan 27, 2020 Option Exercise $8.16 14,467 118,051 608,385 Jan 27, 2020, 05:41 PM
Oney Sabah Chief Business Officer Jan 27, 2020 Sale $25.05 14,467 362,398 593,918 Jan 27, 2020, 05:41 PM
Oney Sabah Chief Business Officer Jan 23, 2020 Sale $25.21 2,200 55,462 593,918 Jan 27, 2020, 05:41 PM
Paul Robert Chief Medical Officer Jan 23, 2020 Option Exercise $8.16 6,000 48,960 279,719 Jan 27, 2020, 05:15 PM
Paul Robert Chief Medical Officer Jan 23, 2020 Sale $24.32 6,000 145,919 274,318 Jan 27, 2020, 05:15 PM
King Robert Chief Development Officer Jan 22, 2020 Sale $22.01 3 66 507,317 Jan 23, 2020, 04:48 PM
King Robert Chief Development Officer Jan 21, 2020 Sale $22.01 14,997 330,084 507,320 Jan 23, 2020, 04:48 PM
Paul Robert Chief Medical Officer Jan 15, 2020 Sale $18.67 10,000 186,700 273,719 Jan 17, 2020, 04:53 PM
ORBIMED ADVISORS LLC 10% Owner Jan 09, 2020 Sale $19.50 379,997 7,409,942 7,992,776 Jan 13, 2020, 04:48 PM
ORBIMED ADVISORS LLC 10% Owner Dec 20, 2019 Sale $19.66 342,500 6,733,550 8,398,697 Dec 26, 2019, 04:54 PM
ORBIMED ADVISORS LLC 10% Owner Dec 26, 2019 Sale $18.60 10,800 200,880 8,279,563 Dec 26, 2019, 04:54 PM
ORBIMED ADVISORS LLC 10% Owner Dec 24, 2019 Sale $19.59 71,800 1,406,562 8,286,838 Dec 26, 2019, 04:54 PM
ORBIMED ADVISORS LLC 10% Owner Dec 23, 2019 Sale $19.82 94,285 1,868,729 8,335,162 Dec 26, 2019, 04:54 PM
ORBIMED ADVISORS LLC 10% Owner Dec 17, 2019 Sale $18.52 954,100 17,669,932 8,629,418 Dec 19, 2019, 04:33 PM
Paul Robert Chief Medical Officer Dec 13, 2019 Sale $20.03 10,000 200,300 283,719 Dec 17, 2019, 05:33 PM
Oney Sabah Chief Business Officer Dec 12, 2019 Option Exercise $8.16 6,810 55,570 600,728 Dec 16, 2019, 08:13 PM
Oney Sabah Chief Business Officer Dec 12, 2019 Sale $20.13 6,810 137,069 593,918 Dec 16, 2019, 08:13 PM
Oney Sabah Chief Business Officer Dec 10, 2019 Option Exercise $8.16 500 4,080 594,418 Dec 12, 2019, 04:34 PM
Oney Sabah Chief Business Officer Dec 10, 2019 Sale $20.01 500 10,005 593,918 Dec 12, 2019, 04:34 PM
Oney Sabah Chief Business Officer Dec 05, 2019 Option Exercise $8.16 1,500 12,240 595,418 Dec 09, 2019, 06:36 PM
Oney Sabah Chief Business Officer Dec 09, 2019 Option Exercise $8.16 2,300 18,768 596,218 Dec 09, 2019, 06:36 PM
Oney Sabah Chief Business Officer Dec 06, 2019 Option Exercise $8.16 5,156 42,073 599,074 Dec 09, 2019, 06:36 PM
Oney Sabah Chief Business Officer Dec 05, 2019 Sale $20.00 1,500 30,000 593,918 Dec 09, 2019, 06:36 PM
Oney Sabah Chief Business Officer Dec 09, 2019 Sale $20.07 2,300 46,161 593,918 Dec 09, 2019, 06:36 PM
Oney Sabah Chief Business Officer Dec 06, 2019 Sale $20.02 5,156 103,223 593,918 Dec 09, 2019, 06:36 PM
Yu Calvin Vice President, Finance Dec 03, 2019 Sale $18.31 1,315 24,078 175,294 Dec 05, 2019, 04:25 PM
King Robert Chief Development Officer Nov 15, 2019 Sale $15.92 7,500 119,400 522,317 Nov 19, 2019, 04:47 PM
Paul Robert Chief Medical Officer Nov 15, 2019 Sale $15.93 10,000 159,300 293,719 Nov 19, 2019, 04:45 PM
Paul Robert Chief Medical Officer Aug 20, 2019 Option Exercise $8.16 916 7,475 324,635 Nov 19, 2019, 04:42 PM
Paul Robert Chief Medical Officer Aug 19, 2019 Option Exercise $8.16 1,084 8,845 324,803 Nov 19, 2019, 04:42 PM
Paul Robert Chief Medical Officer Aug 20, 2019 Sale $16.00 916 14,656 323,719 Nov 19, 2019, 04:42 PM
Paul Robert Chief Medical Officer Aug 19, 2019 Sale $16.00 1,084 17,344 323,719 Nov 19, 2019, 04:42 PM
Paul Robert Chief Medical Officer Oct 15, 2019 Sale $14.68 10,000 146,800 301,719 Oct 17, 2019, 06:15 PM
Oney Sabah Chief Business Officer Sep 20, 2019 Option Exercise $8.16 400 3,264 594,318 Sep 24, 2019, 06:34 PM
Oney Sabah Chief Business Officer Sep 20, 2019 Sale $20.00 400 8,000 593,918 Sep 24, 2019, 06:34 PM
Paul Robert Chief Medical Officer Sep 20, 2019 Option Exercise $8.16 4,000 32,640 315,719 Sep 24, 2019, 06:33 PM
Paul Robert Chief Medical Officer Sep 20, 2019 Sale $20.00 4,000 80,000 311,719 Sep 24, 2019, 06:33 PM
Paul Robert Chief Medical Officer Sep 16, 2019 Sale $19.08 10,000 190,800 311,719 Sep 18, 2019, 05:33 PM
King Robert Chief Development Officer Aug 19, 2019 Sale $15.00 7,500 112,500 529,817 Aug 21, 2019, 04:26 PM
Paul Robert Chief Medical Officer Aug 20, 2019 Sale $16.00 916 14,656 321,719 Aug 21, 2019, 04:18 PM
Paul Robert Chief Medical Officer Aug 19, 2019 Sale $16.00 1,084 17,344 322,635 Aug 21, 2019, 04:18 PM
Paul Robert Chief Medical Officer Aug 15, 2019 Sale $14.19 10,000 141,900 323,719 Aug 19, 2019, 05:19 PM
ORBIMED ADVISORS LLC 10% Owner Aug 07, 2019 Sale $17.90 650,000 11,635,000 9,272,225 Aug 09, 2019, 06:41 PM
ORBIMED ADVISORS LLC Director Feb 11, 2019 Buy $19.00 411,700 7,822,300 10,434,976 Feb 11, 2019, 07:11 PM
GORDON CARL L Director Feb 11, 2019 Buy $19.00 411,700 7,822,300 10,434,976 Feb 11, 2019, 07:06 PM
Load More Insider Transactions
Buy Sale Option Exercise
Owner Relationship Date Value($)
King Robert Chief Development Officer 03/01/2022 4,468
SULIMAN SHEHNAAZ President and COO 12/10/2021 1,292,250
SULIMAN SHEHNAAZ President and COO 12/13/2021 1,292,250
SULIMAN SHEHNAAZ President and COO 12/10/2021 1,632,167
SULIMAN SHEHNAAZ President and COO 12/13/2021 1,593,149
SULIMAN SHEHNAAZ President and COO 12/08/2021 906,493
SULIMAN SHEHNAAZ President and COO 12/09/2021 1,292,250
SULIMAN SHEHNAAZ President and COO 12/09/2021 1,711,843
SULIMAN SHEHNAAZ President and COO 12/08/2021 1,709,316
King Robert Chief Development Officer 12/01/2021 5,023
Rosenthal Arnon Chief Executive Officer 11/11/2021 1,375,000
Rosenthal Arnon Chief Executive Officer 11/10/2021 1,375,000
Rosenthal Arnon Chief Executive Officer 11/08/2021 2,500,000
Rosenthal Arnon Chief Executive Officer 11/09/2021 2,500,000
Rosenthal Arnon Chief Executive Officer 11/05/2021 2,500,000
Rosenthal Arnon Chief Executive Officer 11/04/2021 2,500,000
Rosenthal Arnon Chief Executive Officer 09/23/2021 241,567
Rosenthal Arnon Chief Executive Officer 09/22/2021 2,533,188
Rosenthal Arnon Chief Executive Officer 09/20/2021 2,580,391
Rosenthal Arnon Chief Executive Officer 09/21/2021 2,611,437
Paul Robert Chief Medical Officer 08/09/2021 245,245
Paul Robert Chief Medical Officer 08/09/2021 623,767
SCHELLER RICHARD H Director 08/05/2021 570,476
SCHELLER RICHARD H Director 07/02/2021 310,808
SCHELLER RICHARD H Director 08/05/2021 1,557,341
Paul Robert Chief Medical Officer 07/07/2021 361,340
Paul Robert Chief Medical Officer 07/06/2021 514,500
Paul Robert Chief Medical Officer 07/07/2021 1,151,237
Paul Robert Chief Medical Officer 07/06/2021 1,119,167
Yu Calvin Vice President, Finance 07/06/2021 43,429
Yu Calvin Vice President, Finance 07/02/2021 798,948
Yu Calvin Vice President, Finance 07/06/2021 115,523
Yu Calvin Vice President, Finance 07/02/2021 3,629,078
King Robert Chief Development Officer 07/02/2021 549,000
King Robert Chief Development Officer 07/02/2021 1,868,400
Paul Robert Chief Medical Officer 07/02/2021 297,141
Paul Robert Chief Medical Officer 07/02/2021 934,200
Paul Robert Chief Medical Officer 07/01/2021 594,124
Paul Robert Chief Medical Officer 06/08/2021 179,996
Paul Robert Chief Medical Officer 06/08/2021 367,745
Yu Calvin Vice President, Finance 06/02/2021 32,768
Paul Robert Chief Medical Officer 04/07/2021 214,186
Paul Robert Chief Medical Officer 04/07/2021 428,050
Paul Robert Chief Medical Officer 03/22/2021 244,800
Paul Robert Chief Medical Officer 03/23/2021 112,608
Paul Robert Chief Medical Officer 03/22/2021 689,376
Paul Robert Chief Medical Officer 03/23/2021 306,498
Paul Robert Chief Medical Officer 03/09/2021 160,592
Paul Robert Chief Medical Officer 03/09/2021 347,405
Paul Robert Chief Medical Officer 02/09/2021 160,594
Paul Robert Chief Medical Officer 02/09/2021 399,055
Paul Robert Chief Medical Officer 01/26/2021 231,082
Paul Robert Chief Medical Officer 01/25/2021 248,926
Paul Robert Chief Medical Officer 01/26/2021 491,544
Paul Robert Chief Medical Officer 01/25/2021 540,225
Paul Robert Chief Medical Officer 01/20/2021 74,031
Paul Robert Chief Medical Officer 01/19/2021 248,924
Paul Robert Chief Medical Officer 01/19/2021 543,552
Paul Robert Chief Medical Officer 01/20/2021 154,211
Paul Robert Chief Medical Officer 07/15/2020 229,642
MCGUIRE TERRANCE Director 06/23/2020 138,063
Polaris Venture Management Co. VI, L.L.C. 10% Owner 06/23/2020 138,063
Paul Robert Chief Medical Officer 06/15/2020 296,137
Yu Calvin Vice President, Finance 06/03/2020 41,981
Paul Robert Chief Medical Officer 05/15/2020 270,026
King Robert Chief Development Officer 05/15/2020 404,958
Paul Robert Chief Medical Officer 04/15/2020 222,700
ORBIMED ADVISORS LLC 10% Owner 04/16/2020 1,463,166
ORBIMED ADVISORS LLC 10% Owner 04/14/2020 546,393
ORBIMED ADVISORS LLC 10% Owner 04/09/2020 6,853,923
ORBIMED ADVISORS LLC 10% Owner 04/08/2020 1,953,821
ORBIMED ADVISORS LLC 10% Owner 04/07/2020 211,827
ORBIMED ADVISORS LLC 10% Owner 03/31/2020 6,125,000
ORBIMED ADVISORS LLC 10% Owner 03/25/2020 1,391,095
ORBIMED ADVISORS LLC 10% Owner 03/24/2020 1,653,896
ORBIMED ADVISORS LLC 10% Owner 03/23/2020 380,278
Paul Robert Chief Medical Officer 03/13/2020 229,286
ORBIMED ADVISORS LLC 10% Owner 03/02/2020 48,729,278
King Robert Chief Development Officer 02/14/2020 443,376
Paul Robert Chief Medical Officer 02/14/2020 295,390
Oney Sabah Chief Business Officer 02/07/2020 697,097
Yu Calvin Vice President, Finance 02/06/2020 16,295
Yu Calvin Vice President, Finance 02/07/2020 98,088
Yu Calvin Vice President, Finance 02/06/2020 91,735
Yu Calvin Vice President, Finance 02/07/2020 841,636
Paul Robert Chief Medical Officer 02/05/2020 81,600
Paul Robert Chief Medical Officer 02/05/2020 321,000
Oney Sabah Chief Business Officer 02/04/2020 136,003
Oney Sabah Chief Business Officer 02/06/2020 3,500
Oney Sabah Chief Business Officer 02/04/2020 500,010
SCHELLER RICHARD H Director 02/04/2020 296,700
Yu Calvin Vice President, Finance 02/04/2020 110,495
Yu Calvin Vice President, Finance 02/04/2020 1,908,772
Wehner David M. Director 02/03/2020 500,000
Paul Robert Chief Medical Officer 01/30/2020 65,280
Paul Robert Chief Medical Officer 01/30/2020 224,000
Oney Sabah Chief Business Officer 01/23/2020 17,952
Oney Sabah Chief Business Officer 01/27/2020 118,051
Oney Sabah Chief Business Officer 01/27/2020 362,398
Oney Sabah Chief Business Officer 01/23/2020 55,462
Paul Robert Chief Medical Officer 01/23/2020 48,960
Paul Robert Chief Medical Officer 01/23/2020 145,919
King Robert Chief Development Officer 01/22/2020 66
King Robert Chief Development Officer 01/21/2020 330,084
Paul Robert Chief Medical Officer 01/15/2020 186,700
ORBIMED ADVISORS LLC 10% Owner 01/09/2020 7,409,942
ORBIMED ADVISORS LLC 10% Owner 12/20/2019 6,733,550
ORBIMED ADVISORS LLC 10% Owner 12/26/2019 200,880
ORBIMED ADVISORS LLC 10% Owner 12/24/2019 1,406,562
ORBIMED ADVISORS LLC 10% Owner 12/23/2019 1,868,729
ORBIMED ADVISORS LLC 10% Owner 12/17/2019 17,669,932
Paul Robert Chief Medical Officer 12/13/2019 200,300
Oney Sabah Chief Business Officer 12/12/2019 55,570
Oney Sabah Chief Business Officer 12/12/2019 137,069
Oney Sabah Chief Business Officer 12/10/2019 4,080
Oney Sabah Chief Business Officer 12/10/2019 10,005
Oney Sabah Chief Business Officer 12/05/2019 12,240
Oney Sabah Chief Business Officer 12/09/2019 18,768
Oney Sabah Chief Business Officer 12/06/2019 42,073
Oney Sabah Chief Business Officer 12/05/2019 30,000
Oney Sabah Chief Business Officer 12/09/2019 46,161
Oney Sabah Chief Business Officer 12/06/2019 103,223
Yu Calvin Vice President, Finance 12/03/2019 24,078
King Robert Chief Development Officer 11/15/2019 119,400
Paul Robert Chief Medical Officer 11/15/2019 159,300
Paul Robert Chief Medical Officer 08/20/2019 7,475
Paul Robert Chief Medical Officer 08/19/2019 8,845
Paul Robert Chief Medical Officer 08/20/2019 14,656
Paul Robert Chief Medical Officer 08/19/2019 17,344
Paul Robert Chief Medical Officer 10/15/2019 146,800
Oney Sabah Chief Business Officer 09/20/2019 3,264
Oney Sabah Chief Business Officer 09/20/2019 8,000
Paul Robert Chief Medical Officer 09/20/2019 32,640
Paul Robert Chief Medical Officer 09/20/2019 80,000
Paul Robert Chief Medical Officer 09/16/2019 190,800
King Robert Chief Development Officer 08/19/2019 112,500
Paul Robert Chief Medical Officer 08/20/2019 14,656
Paul Robert Chief Medical Officer 08/19/2019 17,344
Paul Robert Chief Medical Officer 08/15/2019 141,900
ORBIMED ADVISORS LLC 10% Owner 08/07/2019 11,635,000
ORBIMED ADVISORS LLC Director 02/11/2019 7,822,300
GORDON CARL L Director 02/11/2019 7,822,300
Load More Insider Transactions
CHANGE IN SHARES OUTSTANDING
STOCK BUYBACKS
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
12/31/2021
09/30/2021
-2.96%
1Q
12/31/2021
03/31/2021
1.30%
3Q
12/31/2021
09/30/2020
3.98%
5Q
12/31/2021
06/30/2020
4.96%
6Q
12/31/2021
03/31/2020
7.48%
7Q
12/31/2021
12/31/2019
30.26%
8Q
12/31/2021
09/30/2019
34.78%
9Q
12/31/2021
06/30/2019
44.52%
10Q
Load More

Period of Report: 12/31/2021

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
09/30/2021
-2.96%
1Q
03/31/2021
1.30%
3Q
09/30/2020
3.98%
5Q
06/30/2020
4.96%
6Q
03/31/2020
7.48%
7Q
12/31/2019
30.26%
8Q
09/30/2019
34.78%
9Q
06/30/2019
44.52%
10Q
Load More